Celltrion today presented positive Phase III data for CT-P47, a biosimilar referencing RoActemra® in patients with moderate-to-severe rheumatoid arthritis (RA), at the Annual European Congress of Rheumatology (EULAR) 2024. The trial demonstrated that CT-P47 has equivalent efficacy and comparable safety…
Kirin Holdings Company, Limited (Kirin Holdings) (TOKYO: 2503) has announced its intention to acquire additional shares of common stock of FANCL Corporation (FANCL) (TOKYO: 4921) through a tender offer and share warrants, with the goal of making FANCL a wholly-owned…
The World Health Organization has released a new guideline outlining effective strategies to foster food environments that support healthy dietary choices. Emphasizing fiscal policies as a pivotal tool, the guideline recommends measures to discourage consumption of foods linked to unhealthy…
Zimbabwe has reached maturity level 3 (ML 3) in the WHO’s classification of regulatory authorities for medicines, marking a significant achievement in healthcare infrastructure. This classification, assessed using WHO’s Global Benchmarking Tool with over 260 indicators, signifies the establishment of…
Today, Takeda has announced a significant step forward in its oncology portfolio with the signing of an option agreement with Ascentage Pharma. This agreement paves the way for Takeda to potentially enter into an exclusive global license for olverembatinib, a…
eClinical Solutions, a global leader in digital clinical software and services, has announced its participation in several upcoming industry events aimed at advancing biopharma efficiency through its elluminate® platform and biometrics services. These engagements come at a pivotal moment as…
CMI Media Group, a global healthcare media strategy agency and part of WPP (NYSE: WPP), has announced a pioneering partnership with KERV Interactive, a leader in AI-powered video analysis, performance, and monetization. This collaboration introduces innovative ‘Video Attention’ metrics tailored…
AstraZeneca’s supplemental New Drug Application (sNDA) for Tagrisso has been accepted and granted Priority Review in the US for treating adult patients with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after chemoradiotherapy (CRT). If…
Genentech, a member of the Roche Group, shared today groundbreaking 5-year findings reaffirming the lasting effectiveness and safety of Evrysdi® (risdiplam) in children diagnosed with Type 1 spinal muscular atrophy (SMA). These insights stem from the open-label extension of the…
Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT), a global leader in messenger RNA medicines, focused on addressing unmet medical needs in infectious diseases and rare liver and respiratory conditions, unveiled Phase 1 findings in healthy volunteers and interim Phase 1b data…
The “Contact Layer Dressings Market – A Global and Regional Analysis: Focus on Region, Country-Level Analysis, and Competitive Landscape – Analysis and Forecast, 2023-2030” report has been added to ResearchAndMarkets.com’s offering. The global contact layer dressings market, valued at $538.3 million in 2022, is…
Helix, a prominent population genomics company, has introduced new clinico-genomic datasets aimed at empowering life science firms in advancing precision medicine drug discovery and development. These datasets, cultivated through Helix’s extensive collaborations with health systems, encompass comprehensive longitudinal clinical and…